Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.R500011-JLR200 on October 5, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
R500011-JLR200v1
46/12/2531    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, S. G.
Right arrow Articles by Michaelis, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, S. G.
Right arrow Articles by Michaelis, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 46, 2531-2558, December 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

Thematic Review

Thematic Review Series: Lipid Posttranslational Modifications. Prelamin A, Zmpste24, misshapen cell nuclei, and progeria—new evidence suggesting that protein farnesylation could be important for disease pathogenesis

Stephen G. Young1,*, Loren G. Fong* and Susan Michaelis1,{dagger}

* Division of Cardiology, Department of Internal Medicine, University of California, Los Angeles, CA 90095
{dagger} Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205

Published, JLR Papers in Press, October 5, 2005. DOI 10.1194/jlr.R500011-JLR200

1 To whom correspondence should be addressed. e-mail: sgyoung{at}mednet.ucla.edu (S.G.Y.); michaelis{at}jhmi.edu (S.M.)

Prelamin A undergoes multistep processing to yield lamin A, a structural protein of the nuclear lamina. Prelamin A terminates with a CAAX motif, which triggers farnesylation of a C-terminal cysteine (the C of the CAAX motif), endoproteolytic release of the last three amino acids (the AAX), and methylation of the newly exposed farnesylcysteine residue. In addition, prelamin A is cleaved a second time, releasing 15 more residues from the C terminus (including the farnesylcysteine methyl ester), generating mature lamin A. This second cleavage step is carried out by an endoplasmic reticulum membrane protease, ZMPSTE24. Interest in the posttranslational processing of prelamin A has increased with the recognition that certain progeroid syndromes can be caused by mutations that lead to an accumulation of farnesyl-prelamin A. Recently, we showed that a key cellular phenotype of these progeroid disorders, misshapen cell nuclei, can be ameliorated by inhibitors of protein farnesylation, suggesting a potential strategy for treating these diseases.

In this article, we review the posttranslational processing of prelamin A, describe several mouse models for progeroid syndromes, explain the mutations underlying several human progeroid syndromes, and summarize recent data showing that misshapen nuclei can be ameliorated by treating cells with protein farnesyltransferase inhibitors.

Supplementary key words protein prenylation • laminopathy • aging • Ste24 • a-factor • lamin A/C


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
L. G. Fong, T. A. Vickers, E. A. Farber, C. Choi, U. J. Yun, Y. Hu, S. H. Yang, C. Coffinier, R. Lee, L. Yin, et al.
Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotides
Hum. Mol. Genet., July 1, 2009; 18(13): 2462 - 2471.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. S. J. Davies, S. H. Yang, E. Farber, R. Lee, S. B. Buck, D. A. Andres, H. P. Spielmann, B. J. Agnew, F. Tamanoi, L. G. Fong, et al.
Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome
J. Lipid Res., January 1, 2009; 50(1): 126 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
J. Barrowman, C. Hamblet, C. M. George, and S. Michaelis
Analysis of Prelamin A Biogenesis Reveals the Nucleus to be a CaaX Processing Compartment
Mol. Biol. Cell, December 1, 2008; 19(12): 5398 - 5408.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
K. Bracha-Drori, K. Shichrur, T. C. Lubetzky, and S. Yalovsky
Functional Analysis of Arabidopsis Postprenylation CaaX Processing Enzymes and Their Function in Subcellular Protein Targeting
Plant Physiology, September 1, 2008; 148(1): 119 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y. Wang, A. A. Panteleyev, D. M. Owens, K. Djabali, C. L. Stewart, and H. J. Worman
Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin
Hum. Mol. Genet., August 1, 2008; 17(15): 2357 - 2369.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Coffinier, S. E. Hudon, R. Lee, E. A. Farber, C. Nobumori, J. H. Miner, D. A. Andres, H. P. Spielmann, C. A. Hrycyna, L. G. Fong, et al.
A Potent HIV Protease Inhibitor, Darunavir, Does Not Inhibit ZMPSTE24 or Lead to an Accumulation of Farnesyl-prelamin A in Cells
J. Biol. Chem., April 11, 2008; 283(15): 9797 - 9804.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
T. Dechat, K. Pfleghaar, K. Sengupta, T. Shimi, D. K. Shumaker, L. Solimando, and R. D. Goldman
Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin
Genes & Dev., April 1, 2008; 22(7): 832 - 853.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. H. Yang, X. Qiao, E. Farber, S. Y. Chang, L. G. Fong, and S. G. Young
Eliminating the Synthesis of Mature Lamin A Reduces Disease Phenotypes in Mice Carrying a Hutchinson-Gilford Progeria Syndrome Allele
J. Biol. Chem., March 14, 2008; 283(11): 7094 - 7099.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. W. Goldberg, I. Huttenlauch, C. J. Hutchison, and R. Stick
Filaments made from A- and B-type lamins differ in structure and organization
J. Cell Sci., January 15, 2008; 121(2): 215 - 225.
[Abstract] [Full Text] [PDF]

Home page
 J Biomol ScreenHome page
S. P. Manandhar, E. R. Hildebrandt, and W. K. Schmidt
Small-Molecule Inhibitors of the Rce1p CaaX Protease
J Biomol Screen, October 1, 2007; 12(7): 983 - 993.
[Abstract] [PDF]

Home page
 PediatricsHome page
M. W. Kieran, L. Gordon, and M. Kleinman
New Approaches to Progeria
Pediatrics, October 1, 2007; 120(4): 834 - 841.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. G. Clarke
HIV protease inhibitors and nuclear lamin processing: Getting the right bells and whistles
PNAS, August 28, 2007; 104(35): 13857 - 13858.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Coffinier, S. E. Hudon, E. A. Farber, S. Y. Chang, C. A. Hrycyna, S. G. Young, and L. G. Fong
From the Cover: HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells
PNAS, August 14, 2007; 104(33): 13432 - 13437.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. L. Kilpatrick and J. D. Hildebrandt
Sequence Dependence and Differential Expression of G{gamma}5 Subunit Isoforms of the Heterotrimeric G Proteins Variably Processed after Prenylation in Mammalian Cells
J. Biol. Chem., May 11, 2007; 282(19): 14038 - 14047.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Cao, B. C. Capell, M. R. Erdos, K. Djabali, and F. S. Collins
A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells
PNAS, March 20, 2007; 104(12): 4949 - 4954.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. Halaschek-Wiener and A. Brooks-Wilson
Progeria of Stem Cells: Stem Cell Exhaustion in Hutchinson-Gilford Progeria Syndrome
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2007; 62(1): 3 - 8.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. G. Young, M. Meta, S. H. Yang, and L. G. Fong
Prelamin A Farnesylation and Progeroid Syndromes
J. Biol. Chem., December 29, 2006; 281(52): 39741 - 39745.
[Abstract] [Full Text] [PDF]

Home page
 Eukaryot CellHome page
G. Huyer, A. Kistler, F. J. Nouvet, C. M. George, M. L. Boyle, and S. Michaelis
Saccharomyces cerevisiae a-Factor Mutants Reveal Residues Critical for Processing, Activity, and Export.
Eukaryot. Cell, September 1, 2006; 5(9): 1560 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. E. Rusinol and M. S. Sinensky
Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors.
J. Cell Sci., August 15, 2006; 119(Pt 16): 3265 - 3272.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
R. T. Nitta, S. A. Jameson, B. A. Kudlow, L. A. Conlan, and B. K. Kennedy
Stabilization of the Retinoblastoma Protein by A-Type Nuclear Lamins Is Required for INK4A-Mediated Cell Cycle Arrest.
Mol. Cell. Biol., July 1, 2006; 26(14): 5360 - 5372.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
J. L. V. Broers, F. C. S. Ramaekers, G. Bonne, R. B. Yaou, and C. J. Hutchison
Nuclear lamins: laminopathies and their role in premature ageing.
Physiol Rev, July 1, 2006; 86(3): 967 - 1008.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. K. Shumaker, T. Dechat, A. Kohlmaier, S. A. Adam, M. R. Bozovsky, M. R. Erdos, M. Eriksson, A. E. Goldman, S. Khuon, F. S. Collins, et al.
From the Cover: Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging
PNAS, June 6, 2006; 103(23): 8703 - 8708.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
D. A. Mitchell, A. Vasudevan, M. E. Linder, and R. J. Deschenes
Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases
J. Lipid Res., June 1, 2006; 47(6): 1118 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
P. Scaffidi and T. Misteli
Lamin A-Dependent Nuclear Defects in Human Aging
Science, May 19, 2006; 312(5776): 1059 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. Delbarre, M. Tramier, M. Coppey-Moisan, C. Gaillard, J.-C. Courvalin, and B. Buendia
The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers
Hum. Mol. Genet., April 1, 2006; 15(7): 1113 - 1122.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. G. Fong, D. Frost, M. Meta, X. Qiao, S. H. Yang, C. Coffinier, and S. G. Young
A Protein Farnesyltransferase Inhibitor Ameliorates Disease in a Mouse Model of Progeria
Science, March 17, 2006; 311(5767): 1621 - 1623.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Varga, M. Eriksson, M. R. Erdos, M. Olive, I. Harten, F. Kolodgie, B. C. Capell, J. Cheng, D. Faddah, S. Perkins, et al.
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome
PNAS, February 28, 2006; 103(9): 3250 - 3255.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement